| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 3.36e-07 | 431 | 158 | 16 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8U1 ADGRL1 OR5A1 OR2A5 OR8U3 ADGRE2 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 OR5J2 NPY4R2 CELSR1 OR1I1 NPY4R OR52D1 OR52E4 OR52E5 OR8B2 ADGRF1 OR52B6 | 4.97e-07 | 884 | 158 | 23 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 OR8U1 GRIA1 ADGRL1 OR5A1 OR2A5 OR8U3 ADGRE2 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 OR5J2 NPY4R2 CELSR1 EFNA3 OR1I1 NPY4R OR52D1 OR52E4 OR52E5 OR8B2 ADGRF1 OR52B6 SORL1 | 7.56e-06 | 1353 | 158 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | odorant binding | 7.77e-06 | 127 | 158 | 8 | GO:0005549 | |
| GeneOntologyMolecularFunction | hepoxilin-epoxide hydrolase activity | 6.22e-05 | 2 | 158 | 2 | GO:0047977 | |
| GeneOntologyMolecularFunction | P-type divalent copper transporter activity | 6.22e-05 | 2 | 158 | 2 | GO:0043682 | |
| GeneOntologyMolecularFunction | P-type monovalent copper transporter activity | 6.22e-05 | 2 | 158 | 2 | GO:0140581 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 1.01e-04 | 12 | 158 | 3 | GO:0019534 | |
| GeneOntologyMolecularFunction | linoleate 13S-lipoxygenase activity | 1.86e-04 | 3 | 158 | 2 | GO:0016165 | |
| GeneOntologyMolecularFunction | arachidonate 15-lipoxygenase activity | 1.86e-04 | 3 | 158 | 2 | GO:0050473 | |
| GeneOntologyMolecularFunction | putrescine transmembrane transporter activity | 3.69e-04 | 4 | 158 | 2 | GO:0015489 | |
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 3.69e-04 | 4 | 158 | 2 | GO:0004052 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 3.69e-04 | 4 | 158 | 2 | GO:0001602 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | AHCYL1 ADCY4 OR8U1 ADGRL1 OR5A1 OR2A5 OR8U3 PDE10A ADGRE2 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 SLIT2 OR5J2 NPY4R2 CELSR1 GAS2L2 OR1I1 NPY4R OR52D1 KCTD16 TENM1 OR52E4 OR52E5 OR8B2 ADGRF1 PREX1 OR52B6 SORL1 | 1.14e-08 | 1395 | 155 | 32 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 1.73e-07 | 432 | 155 | 16 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 4.64e-07 | 465 | 155 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 8.10e-07 | 485 | 155 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 SCNN1A OR52E4 OR52E5 OR8B2 OR52B6 | 8.21e-07 | 547 | 155 | 17 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 2.21e-06 | 524 | 155 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 8.37e-06 | 582 | 155 | 16 | GO:0050906 |
| GeneOntologyBiologicalProcess | cholesterol efflux | 2.50e-05 | 77 | 155 | 6 | GO:0033344 | |
| GeneOntologyBiologicalProcess | cholesterol storage | 4.03e-05 | 26 | 155 | 4 | GO:0010878 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol efflux | 6.30e-05 | 56 | 155 | 5 | GO:0010874 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | ATP7A NCKAP1 ACTB ACTG1 TEAD1 PGF RXRA ZNF568 SLIT2 LHX2 CELSR1 EGF MTHFR ALOX12 SMAD4 | 6.89e-05 | 619 | 155 | 15 | GO:0002009 |
| GeneOntologyBiologicalProcess | cholesterol transport | 6.99e-05 | 134 | 155 | 7 | GO:0030301 | |
| GeneOntologyBiologicalProcess | sterol transport | 8.80e-05 | 139 | 155 | 7 | GO:0015918 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 1.11e-04 | 722 | 155 | 16 | GO:0051606 |
| GeneOntologyBiologicalProcess | intracellular cholesterol transport | 1.50e-04 | 36 | 155 | 4 | GO:0032367 | |
| GeneOntologyBiologicalProcess | sensory perception | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 AQP4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 OR5J2 GRXCR2 OR1I1 OR52D1 SCNN1A OR52E4 OR52E5 OR8B2 OR52B6 | 1.60e-04 | 1072 | 155 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | copper ion export | 1.67e-04 | 3 | 155 | 2 | GO:0060003 | |
| GeneOntologyBiologicalProcess | lipoxin A4 biosynthetic process | 1.67e-04 | 3 | 155 | 2 | GO:2001303 | |
| GeneOntologyBiologicalProcess | intracellular sterol transport | 2.06e-04 | 39 | 155 | 4 | GO:0032366 | |
| GeneOntologyBiologicalProcess | apical protein localization | 2.62e-04 | 17 | 155 | 3 | GO:0045176 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 3.33e-04 | 4 | 155 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | lipoxin A4 metabolic process | 3.33e-04 | 4 | 155 | 2 | GO:2001302 | |
| GeneOntologyBiologicalProcess | lipoxin biosynthetic process | 3.33e-04 | 4 | 155 | 2 | GO:2001301 | |
| GeneOntologyBiologicalProcess | putrescine transport | 3.33e-04 | 4 | 155 | 2 | GO:0015847 | |
| MousePheno | abnormal locomotor coordination | NPC1 ZNF597 ZBTB16 ATP7A ATP7B STXBP5 CNTNAP1 GRIA1 DAPK1 LRRK1 MEI1 LYST SIL1 CCR2 NEU1 PLAA ALDH5A1 AGTPBP1 SORL1 | 2.33e-05 | 726 | 125 | 19 | MP:0003312 |
| MousePheno | abnormal kidney copper level | 7.93e-05 | 2 | 125 | 2 | MP:0010242 | |
| MousePheno | increased kidney copper level | 7.93e-05 | 2 | 125 | 2 | MP:0010243 | |
| MousePheno | increased brain copper level | 7.93e-05 | 2 | 125 | 2 | MP:0011214 | |
| MousePheno | decreased cholesterol level | NPC1 PCSK5 TMEM248 CES1 ACTB SREBF2 BAZ1B WDR27 PDE10A ZZEF1 TBL1XR1 ATP13A3 ABHD8 | 9.31e-05 | 418 | 125 | 13 | MP:0003983 |
| MousePheno | decreased sterol level | NPC1 PCSK5 TMEM248 CES1 ACTB SREBF2 BAZ1B WDR27 PDE10A ZZEF1 TBL1XR1 ATP13A3 ABHD8 | 1.00e-04 | 421 | 125 | 13 | MP:0012225 |
| MousePheno | paresis | 1.07e-04 | 53 | 125 | 5 | MP:0000754 | |
| MousePheno | abnormal cardiac output | 1.40e-04 | 56 | 125 | 5 | MP:0001627 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 1.59e-04 | 220 | 125 | 9 | MP:0000875 | |
| Domain | Olfact_rcpt | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 2.36e-07 | 393 | 158 | 16 | IPR000725 |
| Domain | 7tm_1 | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 OR5J2 NPY4R2 OR1I1 NPY4R OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 4.67e-06 | 677 | 158 | 19 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 OR5J2 NPY4R2 OR1I1 NPY4R OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 5.53e-06 | 685 | 158 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 OR5J2 NPY4R2 OR1I1 NPY4R OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 6.26e-06 | 691 | 158 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 CCR2 OR5J2 NPY4R2 OR1I1 NPY4R OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 6.39e-06 | 692 | 158 | 19 | IPR000276 |
| Domain | EGF-like_dom | PCSK5 ADAM18 MATN2 CNTNAP1 ADGRE2 SLIT2 CELSR1 EGF TENM1 MEGF11 SORL1 | 9.10e-06 | 249 | 158 | 11 | IPR000742 |
| Domain | EGF | PCSK5 MATN2 CNTNAP1 ADGRE2 SLIT2 CELSR1 EGF TENM1 MEGF11 SORL1 | 3.23e-05 | 235 | 158 | 10 | SM00181 |
| Domain | EGF_3 | ADAM18 MATN2 CNTNAP1 ADGRE2 SLIT2 CELSR1 EGF TENM1 MEGF11 SORL1 | 3.23e-05 | 235 | 158 | 10 | PS50026 |
| Domain | GPCR_Rhodpsn_7TM | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR12D3 CCR2 OR5J2 NPY4R2 OR1I1 NPY4R OR52D1 OR52E4 OR8B2 OR52B6 | 5.46e-05 | 670 | 158 | 17 | IPR017452 |
| Domain | P-typ_ATPase_IB | 7.11e-05 | 2 | 158 | 2 | IPR027256 | |
| Domain | NPY4_rcpt | 7.11e-05 | 2 | 158 | 2 | IPR001933 | |
| Domain | HMA_Cu_ion-bd | 7.11e-05 | 2 | 158 | 2 | IPR006122 | |
| Domain | EGF-like_CS | ADAM18 MATN2 CNTNAP1 ADGRE2 SLIT2 CELSR1 EGF TENM1 MEGF11 SORL1 | 7.81e-05 | 261 | 158 | 10 | IPR013032 |
| Domain | EGF_2 | ADAM18 MATN2 CNTNAP1 ADGRE2 SLIT2 CELSR1 EGF TENM1 MEGF11 SORL1 | 8.85e-05 | 265 | 158 | 10 | PS01186 |
| Domain | ARM-type_fold | RELCH GBF1 ARFGEF1 MEI1 LYST SIL1 URB1 PLAA AP2A1 USP35 AGTPBP1 | 1.50e-04 | 339 | 158 | 11 | IPR016024 |
| Domain | GPS | 1.88e-04 | 34 | 158 | 4 | SM00303 | |
| Domain | GPS | 2.10e-04 | 35 | 158 | 4 | PF01825 | |
| Domain | Teashirt_fam | 2.12e-04 | 3 | 158 | 2 | IPR027008 | |
| Domain | Heavy-metal-associated_CS | 2.12e-04 | 3 | 158 | 2 | IPR017969 | |
| Domain | GPS | 2.35e-04 | 36 | 158 | 4 | PS50221 | |
| Domain | - | 2.51e-04 | 15 | 158 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 2.51e-04 | 15 | 158 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 2.51e-04 | 15 | 158 | 3 | IPR023394 | |
| Domain | GPS | 2.62e-04 | 37 | 158 | 4 | IPR000203 | |
| Domain | SEC7 | 3.07e-04 | 16 | 158 | 3 | PS50190 | |
| Domain | Sec7 | 3.07e-04 | 16 | 158 | 3 | SM00222 | |
| Domain | Sec7_dom | 3.07e-04 | 16 | 158 | 3 | IPR000904 | |
| Domain | HMA | 4.22e-04 | 4 | 158 | 2 | PF00403 | |
| Domain | ROC_dom | 4.22e-04 | 4 | 158 | 2 | IPR020859 | |
| Domain | ROC | 4.22e-04 | 4 | 158 | 2 | PS51424 | |
| Domain | Sec7_N | 4.22e-04 | 4 | 158 | 2 | IPR032691 | |
| Domain | Sec7_N | 4.22e-04 | 4 | 158 | 2 | PF12783 | |
| Domain | HMA_2 | 4.22e-04 | 4 | 158 | 2 | PS50846 | |
| Domain | HMA_1 | 4.22e-04 | 4 | 158 | 2 | PS01047 | |
| Domain | Znf_C2H2 | ZNF597 ZNF346 ZNF536 ZBTB16 ZNF680 TSHZ2 ZNF652 ADNP2 ZNF416 ZNF568 ZBTB14 ZNF490 ZBTB39 SCAPER ZNF525 TSHZ1 ZMAT1 | 4.80e-04 | 805 | 158 | 17 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF597 ZNF346 ZNF536 ZBTB16 ZNF680 TSHZ2 ZNF652 ADNP2 ZNF416 ZNF568 ZBTB14 ZNF490 ZBTB39 SCAPER ZNF525 TSHZ1 ZMAT1 | 5.00e-04 | 808 | 158 | 17 | SM00355 |
| Domain | 7tm_2 | 8.39e-04 | 50 | 158 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 8.39e-04 | 50 | 158 | 4 | PS00650 | |
| Domain | LipOase_mml | 1.04e-03 | 6 | 158 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 1.04e-03 | 6 | 158 | 2 | PS00711 | |
| Domain | LipOase_C | 1.04e-03 | 6 | 158 | 2 | IPR013819 | |
| Domain | LIPOXYGENASE_2 | 1.04e-03 | 6 | 158 | 2 | PS00081 | |
| Domain | LipOase_Fe_BS | 1.04e-03 | 6 | 158 | 2 | IPR020833 | |
| Domain | LipOase_CS | 1.04e-03 | 6 | 158 | 2 | IPR020834 | |
| Domain | Lipoxygenase | 1.04e-03 | 6 | 158 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 1.04e-03 | 6 | 158 | 2 | PS51393 | |
| Domain | LipOase | 1.04e-03 | 6 | 158 | 2 | IPR000907 | |
| Domain | Znf_C2H2-like | ZNF597 ZNF346 ZNF536 ZBTB16 ZNF680 TSHZ2 ZNF652 ADNP2 ZNF416 ZNF568 ZBTB14 ZNF490 ZBTB39 SCAPER TSHZ1 ZMAT1 | 1.19e-03 | 796 | 158 | 16 | IPR015880 |
| Domain | HMA_dom | 1.45e-03 | 7 | 158 | 2 | IPR006121 | |
| Domain | EGF_1 | 1.50e-03 | 255 | 158 | 8 | PS00022 | |
| Domain | ASX_HYDROXYL | 1.60e-03 | 100 | 158 | 5 | PS00010 | |
| Domain | GPCR_2_secretin-like | 1.66e-03 | 60 | 158 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 1.66e-03 | 60 | 158 | 4 | IPR017981 | |
| Domain | LisH | 1.67e-03 | 28 | 158 | 3 | IPR006594 | |
| Domain | LisH | 1.67e-03 | 28 | 158 | 3 | SM00667 | |
| Domain | LISH | 1.67e-03 | 28 | 158 | 3 | PS50896 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.77e-03 | 61 | 158 | 4 | PS50261 | |
| Domain | Znf_U1 | 1.85e-03 | 29 | 158 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 1.85e-03 | 29 | 158 | 3 | SM00451 | |
| Domain | ACTINS_1 | 1.93e-03 | 8 | 158 | 2 | PS00406 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.07e-03 | 106 | 158 | 5 | IPR000152 | |
| Domain | ARM-like | 2.14e-03 | 270 | 158 | 8 | IPR011989 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF597 ZNF536 ZBTB16 ZNF680 TSHZ2 ZNF652 ADNP2 ZNF416 ZNF568 ZBTB14 ZNF490 ZBTB39 SCAPER ZNF525 TSHZ1 | 2.43e-03 | 775 | 158 | 15 | PS50157 |
| Domain | - | 2.46e-03 | 32 | 158 | 3 | 3.40.1110.10 | |
| Domain | - | 2.46e-03 | 32 | 158 | 3 | 2.70.150.10 | |
| Domain | LisH | 2.46e-03 | 9 | 158 | 2 | PF08513 | |
| Domain | Sialidases | 2.46e-03 | 9 | 158 | 2 | IPR011040 | |
| Domain | NPY_rcpt | 2.46e-03 | 9 | 158 | 2 | IPR000611 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF597 ZNF536 ZBTB16 ZNF680 TSHZ2 ZNF652 ADNP2 ZNF416 ZNF568 ZBTB14 ZNF490 ZBTB39 SCAPER ZNF525 TSHZ1 | 2.49e-03 | 777 | 158 | 15 | PS00028 |
| Domain | ATPase_P-typ_cyto_domN | 3.19e-03 | 35 | 158 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 3.46e-03 | 36 | 158 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 3.46e-03 | 36 | 158 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 3.46e-03 | 36 | 158 | 3 | PS00154 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8U1 ACTB ACTG1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 LHX2 OR5J2 GRXCR2 OR1I1 OR52D1 SCNN1A OR52E4 OR52E5 OR8B2 OR52B6 | 3.30e-08 | 636 | 114 | 21 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR8B3 OR10G6 OR12D3 LHX2 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 3.93e-08 | 417 | 114 | 17 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8U8 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52B6 | 7.20e-05 | 389 | 114 | 12 | M14091 |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 8.11e-05 | 11 | 114 | 3 | M18837 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 8.11e-05 | 11 | 114 | 3 | MM1432 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.39e-04 | 13 | 114 | 3 | MM15622 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 | 9.08e-10 | 340 | 163 | 14 | 11875048 |
| Pubmed | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 | 9.08e-10 | 340 | 163 | 14 | 11802173 | |
| Pubmed | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 | 1.02e-09 | 343 | 163 | 14 | 32295537 | |
| Pubmed | OR8U1 OR5A1 OR2A5 OR8U3 OR2T4 OR8B3 OR10G6 OR12D3 OR5J2 OR1I1 OR52D1 OR52E4 OR52E5 OR8B2 | 1.14e-09 | 346 | 163 | 14 | 14611657 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZNF536 GBF1 NCKAP1 TBL1Y MCM4 TBL1XR1 ADAR RXRA SMYD2 LDB2 RINT1 TSHZ1 HSPA14 TOP2A AGTPBP1 SMAD4 SORL1 | 6.51e-07 | 857 | 163 | 17 | 25609649 |
| Pubmed | NPC1 GBF1 ATP7A ATP7B STXBP5 ANGEL1 SREBF2 ARFGEF1 FYCO1 LYST RINT1 TENM1 | 5.06e-06 | 504 | 163 | 12 | 34432599 | |
| Pubmed | ZNF536 ATP7B ANGEL1 ADNP2 BAZ1B TUBGCP2 ZZEF1 SLIT2 SULF2 MTHFR SCAPER SLC25A11 ABHD8 USP54 SLC25A19 TOP2A AGTPBP1 SORL1 | 5.54e-06 | 1116 | 163 | 18 | 31753913 | |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 19713213 | ||
| Pubmed | OR5A1 OR8U3 OR2T4 OR8B3 OR10G6 OR12D3 OR5J2 OR52D1 OR52E4 OR52E5 OR8B2 OR52B6 | 1.03e-05 | 541 | 163 | 12 | 14983052 | |
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 1.62e-05 | 11 | 163 | 3 | 23294842 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.71e-05 | 33 | 163 | 4 | 25713288 | |
| Pubmed | 2.17e-05 | 35 | 163 | 4 | 23291589 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29394468 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.18e-05 | 2 | 163 | 2 | 21778137 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8082762 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30792307 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25251155 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33113941 | ||
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.18e-05 | 2 | 163 | 2 | 22366783 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15708862 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18045816 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19645496 | ||
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 2.18e-05 | 2 | 163 | 2 | 32588558 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21115196 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8622986 | ||
| Pubmed | Enhancement role of host 12/15-lipoxygenase in melanoma progression. | 2.18e-05 | 2 | 163 | 2 | 23664097 | |
| Pubmed | Lipoxygenase metabolites are mediators of PTH-dependent human osteoblast growth. | 2.18e-05 | 2 | 163 | 2 | 18187376 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27625340 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32610130 | ||
| Pubmed | Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B. | 2.18e-05 | 2 | 163 | 2 | 28164426 | |
| Pubmed | Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. | 2.18e-05 | 2 | 163 | 2 | 17079330 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22089472 | ||
| Pubmed | Biochemical basis of regulation of human copper-transporting ATPases. | 2.18e-05 | 2 | 163 | 2 | 17562324 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 9823011 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33270289 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19787041 | ||
| Pubmed | Expression and regulation of mouse Mtsh1 during limb and branchial arch development. | 2.18e-05 | 2 | 163 | 2 | 11668608 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18547056 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17717039 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18780776 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20045993 | ||
| Pubmed | The evolutionary hypothesis of reaction specificity of mammalian ALOX15 orthologs. | 2.18e-05 | 2 | 163 | 2 | 30237084 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 38032054 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 3221869 | ||
| Pubmed | Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer. | 2.18e-05 | 2 | 163 | 2 | 31358848 | |
| Pubmed | Stimulation of mGluR1/5 Improves Defective Internalization of AMPA Receptors in NPC1 Mutant Mouse. | 2.18e-05 | 2 | 163 | 2 | 31599924 | |
| Pubmed | Human ALOX12, but not ALOX15, is associated with BMD in white men and women. | 2.18e-05 | 2 | 163 | 2 | 16598376 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17008555 | ||
| Pubmed | Molecular features of copper binding proteins involved in copper homeostasis. | 2.18e-05 | 2 | 163 | 2 | 27896900 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15681297 | ||
| Pubmed | Vertebrate orthologues of the Drosophila region-specific patterning gene teashirt. | 2.18e-05 | 2 | 163 | 2 | 10704881 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29184033 | ||
| Pubmed | Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. | 2.18e-05 | 2 | 163 | 2 | 10330425 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 37553985 | ||
| Pubmed | Reciprocal regulation of 12- and 15-lipoxygenases by UV-irradiation in human keratinocytes. | 2.18e-05 | 2 | 163 | 2 | 18755188 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28271598 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26485751 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21502360 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 6686106 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 213279 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33334799 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25293588 | ||
| Pubmed | Striatonigral direct pathway activation is sufficient to induce repetitive behaviors. | 2.18e-05 | 2 | 163 | 2 | 28939413 | |
| Pubmed | Kinetic investigations of the rate-limiting step in human 12- and 15-lipoxygenase. | 2.18e-05 | 2 | 163 | 2 | 12731864 | |
| Pubmed | The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. | 2.18e-05 | 2 | 163 | 2 | 22267335 | |
| Pubmed | [Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases]. | 2.18e-05 | 2 | 163 | 2 | 21117320 | |
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 2.18e-05 | 2 | 163 | 2 | 21900491 | |
| Pubmed | Overexpression of 12/15-lipoxygenase increases anxiety behavior in female mice. | 2.18e-05 | 2 | 163 | 2 | 24300237 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30225910 | ||
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 2.18e-05 | 2 | 163 | 2 | 19638415 | |
| Pubmed | [From gene to disease: copper-transporting P ATPases alteration]. | 2.18e-05 | 2 | 163 | 2 | 19046832 | |
| Pubmed | Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. | 2.18e-05 | 2 | 163 | 2 | 30472260 | |
| Pubmed | Glutathione disulfide induces neural cell death via a 12-lipoxygenase pathway. | 2.18e-05 | 2 | 163 | 2 | 19373248 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 2.18e-05 | 2 | 163 | 2 | 3335520 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 9288906 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 1577857 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19095999 | ||
| Pubmed | Delayed embryonic development and impaired cell growth and survival in Actg1 null mice. | 2.18e-05 | 2 | 163 | 2 | 20662086 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21094135 | ||
| Pubmed | Expression in mouse kidney of membrane copper transporters Atp7a and Atp7b. | 2.18e-05 | 2 | 163 | 2 | 12372948 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18565219 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21220563 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12539960 | ||
| Pubmed | 12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma. | 2.18e-05 | 2 | 163 | 2 | 23528921 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31016788 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26583190 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32326615 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17109627 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18688737 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32760397 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25187369 | ||
| Pubmed | 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response. | 2.18e-05 | 2 | 163 | 2 | 22215650 | |
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 2.18e-05 | 2 | 163 | 2 | 23756437 | |
| Pubmed | Expression and localization of menkes and Wilson copper transporting ATPases in human placenta. | 2.18e-05 | 2 | 163 | 2 | 15135234 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 9215673 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19469483 | ||
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 2.18e-05 | 2 | 163 | 2 | 8482333 | |
| Pubmed | Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins. | 2.18e-05 | 2 | 163 | 2 | 18000748 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15111312 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17520163 | ||
| GeneFamily | ATPase copper transporting | 4.22e-05 | 2 | 118 | 2 | 1212 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 ZNF536 ZBTB16 ZNF680 TSHZ2 ZNF652 ADNP2 ZNF416 ZNF568 ZBTB14 ZNF490 ZBTB39 SCAPER ZNF525 TSHZ1 | 6.74e-05 | 718 | 118 | 15 | 28 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.16e-04 | 15 | 118 | 3 | 529 | |
| GeneFamily | Olfactory receptors, family 8 | 2.91e-04 | 49 | 118 | 4 | 155 | |
| GeneFamily | Olfactory receptors, family 52 | 2.91e-04 | 49 | 118 | 4 | 165 | |
| GeneFamily | Actins | 6.23e-04 | 6 | 118 | 2 | 929 | |
| GeneFamily | Arachidonate lipoxygenases | 6.23e-04 | 6 | 118 | 2 | 407 | |
| GeneFamily | WD repeat domain containing | 1.67e-03 | 262 | 118 | 7 | 362 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | GBF1 ACTB PSD3 ACTG1 DAPK1 ZZEF1 TBL1XR1 PGF SULF2 MNAT1 PREX1 FGGY TOP2A | 1.91e-06 | 441 | 152 | 13 | M172 |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-08 | 194 | 160 | 9 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.20e-08 | 197 | 160 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-07 | 183 | 160 | 8 | ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-07 | 184 | 160 | 8 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-07 | 185 | 160 | 8 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-07 | 189 | 160 | 8 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-07 | 189 | 160 | 8 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.39e-07 | 199 | 160 | 8 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-07 | 199 | 160 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.63e-07 | 200 | 160 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.63e-07 | 200 | 160 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.94e-06 | 161 | 160 | 7 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 173 | 160 | 7 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-06 | 174 | 160 | 7 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 176 | 160 | 7 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 176 | 160 | 7 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.64e-06 | 177 | 160 | 7 | 7e799333307448c6a94d1f33dbc59c543336f45e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 179 | 160 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 182 | 160 | 7 | 3dec003bad0f3716cf8163861a9d4302a7d6df8c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-06 | 184 | 160 | 7 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 185 | 160 | 7 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 185 | 160 | 7 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-06 | 186 | 160 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.23e-06 | 187 | 160 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-06 | 189 | 160 | 7 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-06 | 189 | 160 | 7 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-06 | 189 | 160 | 7 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.60e-06 | 189 | 160 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-06 | 190 | 160 | 7 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 6.00e-06 | 191 | 160 | 7 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-06 | 193 | 160 | 7 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.43e-06 | 193 | 160 | 7 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | droplet-Lung-LUNG-1m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 194 | 160 | 7 | 621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9 | |
| ToppCell | droplet-Lung-1m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.65e-06 | 194 | 160 | 7 | d16ab5f0cfe73afe6c551fd3123d14784a082f56 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.85e-06 | 199 | 160 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 51265e30f1138fd79733001d0db759f3dab0aaeb | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-05 | 140 | 160 | 6 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 142 | 160 | 6 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 142 | 160 | 6 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 159 | 160 | 6 | c186bf05c61fac348cf41973827cced83fafd58a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.57e-05 | 161 | 160 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 163 | 160 | 6 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.76e-05 | 163 | 160 | 6 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 164 | 160 | 6 | 4ade97931ae1780af7836d988fe117a10b3e88a1 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-05 | 167 | 160 | 6 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-05 | 168 | 160 | 6 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.61e-05 | 171 | 160 | 6 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 3.73e-05 | 172 | 160 | 6 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.98e-05 | 174 | 160 | 6 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 176 | 160 | 6 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 176 | 160 | 6 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-05 | 179 | 160 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.80e-05 | 180 | 160 | 6 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-05 | 183 | 160 | 6 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-05 | 183 | 160 | 6 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-05 | 184 | 160 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 184 | 160 | 6 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 184 | 160 | 6 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 184 | 160 | 6 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.43e-05 | 184 | 160 | 6 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 185 | 160 | 6 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-05 | 185 | 160 | 6 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 185 | 160 | 6 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-05 | 185 | 160 | 6 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 185 | 160 | 6 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 186 | 160 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 186 | 160 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 187 | 160 | 6 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 187 | 160 | 6 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 189 | 160 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.48e-05 | 190 | 160 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.48e-05 | 190 | 160 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 6.67e-05 | 191 | 160 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.67e-05 | 191 | 160 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.67e-05 | 191 | 160 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 6.87e-05 | 192 | 160 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 160 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.87e-05 | 192 | 160 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-05 | 193 | 160 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-05 | 193 | 160 | 6 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 7.07e-05 | 193 | 160 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 7.27e-05 | 194 | 160 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.48e-05 | 195 | 160 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-05 | 195 | 160 | 6 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.48e-05 | 195 | 160 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | CV-Severe|CV / Virus stimulation, Condition and Cluster | 7.69e-05 | 196 | 160 | 6 | d0ddeaaa9ad0576e312a49bd3e68d12addccad3c | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 7.91e-05 | 197 | 160 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.91e-05 | 197 | 160 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.91e-05 | 197 | 160 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.14e-05 | 198 | 160 | 6 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.14e-05 | 198 | 160 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.14e-05 | 198 | 160 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.14e-05 | 198 | 160 | 6 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | distal-Endothelial-Artery|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.36e-05 | 199 | 160 | 6 | b6e9aaac047d4b64b9d97f5e174e89a424d8b36d | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.60e-05 | 200 | 160 | 6 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.60e-05 | 200 | 160 | 6 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | GBF1 DYNC2H1 ADGRL1 AARSD1 EFNA3 KCNG1 MTHFR SCAPER ALDH5A1 SORL1 | 1.19e-06 | 195 | 159 | 10 | 834_UP |
| Disease | occipital horn syndrome (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0111272 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 2.71e-05 | 2 | 154 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 2.71e-05 | 2 | 154 | 2 | C1855722 | |
| Disease | gastrointestinal system cancer (is_implicated_in) | 2.71e-05 | 2 | 154 | 2 | DOID:3119 (is_implicated_in) | |
| Disease | Fryns-Aftimos Syndrome | 2.71e-05 | 2 | 154 | 2 | C1853623 | |
| Disease | sensory system disease (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.27e-04 | 19 | 154 | 3 | DOID:9562 (implicated_via_orthology) | |
| Disease | metal metabolism disorder (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:896 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ADAMTS19 ATP7B DYNC2H1 SREBF2 ADAR OR12D3 SLC2A10 SULF2 EGF MTHFR TENM1 ANKRD30A USP54 HSPA14 TOP2A SORL1 | 1.65e-04 | 1074 | 154 | 16 | C0006142 |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.60e-04 | 24 | 154 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | X-24020 measurement | 2.68e-04 | 5 | 154 | 2 | EFO_0022128 | |
| Disease | Wilson disease (implicated_via_orthology) | 2.68e-04 | 5 | 154 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | Neurologic Symptoms | 2.68e-04 | 5 | 154 | 2 | C0235031 | |
| Disease | Neurological observations | 2.68e-04 | 5 | 154 | 2 | C0422837 | |
| Disease | Neurologic Manifestations | 2.68e-04 | 5 | 154 | 2 | C0027854 | |
| Disease | Menkes disease (implicated_via_orthology) | 2.68e-04 | 5 | 154 | 2 | DOID:1838 (implicated_via_orthology) | |
| Disease | Neurologic Dysfunction | 2.68e-04 | 5 | 154 | 2 | C0751377 | |
| Disease | Neurologic Signs | 2.68e-04 | 5 | 154 | 2 | C0751378 | |
| Disease | Focal Neurologic Deficits | 2.68e-04 | 5 | 154 | 2 | C0746857 | |
| Disease | Colorectal Carcinoma | RELCH ATP7B AMDHD2 ARFGEF1 ITPRID1 ABCG1 CORO2B MTHFR TENM1 AGTPBP1 SMAD4 SORL1 | 3.32e-04 | 702 | 154 | 12 | C0009402 |
| Disease | Neurologic Deficits | 4.00e-04 | 6 | 154 | 2 | C0521654 | |
| Disease | VACTERL association (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | N1-methyladenosine measurement | 4.00e-04 | 6 | 154 | 2 | EFO_0021122 | |
| Disease | Meniere's disease (is_implicated_in) | 4.00e-04 | 6 | 154 | 2 | DOID:9849 (is_implicated_in) | |
| Disease | grip strength measurement | 5.27e-04 | 350 | 154 | 8 | EFO_0006941 | |
| Disease | Liver diseases | 5.57e-04 | 72 | 154 | 4 | C0023895 | |
| Disease | Liver Dysfunction | 5.57e-04 | 72 | 154 | 4 | C0086565 | |
| Disease | Uveoretinal Coloboma | 5.59e-04 | 7 | 154 | 2 | C4554007 | |
| Disease | response to vaccine, cytokine measurement | 6.37e-04 | 131 | 154 | 5 | EFO_0004645, EFO_0004873 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 7.42e-04 | 8 | 154 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 7.42e-04 | 8 | 154 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 7.42e-04 | 8 | 154 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 7.42e-04 | 8 | 154 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 9.51e-04 | 9 | 154 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | Congenital ocular coloboma (disorder) | 9.51e-04 | 9 | 154 | 2 | C0009363 | |
| Disease | Kidney Diseases | 1.18e-03 | 88 | 154 | 4 | C0022658 | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.18e-03 | 10 | 154 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | Congenital neurologic anomalies | 1.18e-03 | 10 | 154 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.18e-03 | 10 | 154 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.18e-03 | 10 | 154 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | polymyositis (is_marker_for) | 1.44e-03 | 11 | 154 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | diet measurement, adiponectin measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0004502, EFO_0008111 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 1.91e-03 | 47 | 154 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 2.36e-03 | 14 | 154 | 2 | C1150929 | |
| Disease | Alopecia, Male Pattern | 2.72e-03 | 15 | 154 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 2.72e-03 | 15 | 154 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 2.72e-03 | 15 | 154 | 2 | C0263477 | |
| Disease | heel bone mineral density, urate measurement | 2.73e-03 | 182 | 154 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | Peripheral Nervous System Diseases | 2.85e-03 | 54 | 154 | 3 | C4721453 | |
| Disease | Tremor, Rubral | 3.10e-03 | 16 | 154 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 3.10e-03 | 16 | 154 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 3.10e-03 | 16 | 154 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 3.10e-03 | 16 | 154 | 2 | C0240991 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 3.10e-03 | 16 | 154 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Abnormal coordination | 3.10e-03 | 16 | 154 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 3.10e-03 | 16 | 154 | 2 | C0427190 | |
| Disease | smoking status measurement | AHCYL1 ZBTB16 GBF1 TSHZ2 JADE2 SREBF2 WDR27 OR5A1 ADAR SMYD2 SLIT2 OR1I1 MEGF11 SORL1 | 3.11e-03 | 1160 | 154 | 14 | EFO_0006527 |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 3.50e-03 | 17 | 154 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Moyamoya Disease | 3.50e-03 | 17 | 154 | 2 | C0026654 | |
| Disease | Familial primary pulmonary hypertension | 3.50e-03 | 17 | 154 | 2 | C0340543 | |
| Disease | dermatomyositis (is_marker_for) | 3.50e-03 | 17 | 154 | 2 | DOID:10223 (is_marker_for) | |
| Disease | C-X-C motif chemokine 16 measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0010911 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 3.92e-03 | 18 | 154 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.02e-03 | 61 | 154 | 3 | DOID:3587 (is_marker_for) | |
| Disease | metabolic syndrome | 4.07e-03 | 200 | 154 | 5 | EFO_0000195 | |
| Disease | Pseudopelade | 4.37e-03 | 19 | 154 | 2 | C0086873 | |
| Disease | Alopecia | 4.37e-03 | 19 | 154 | 2 | C0002170 | |
| Disease | Deaf Mutism | 4.83e-03 | 20 | 154 | 2 | C4082305 | |
| Disease | COVID-19, osteoarthritis | 4.83e-03 | 20 | 154 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 4.83e-03 | 20 | 154 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Deafness, Acquired | 4.83e-03 | 20 | 154 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.83e-03 | 20 | 154 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.83e-03 | 20 | 154 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 4.83e-03 | 20 | 154 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 4.83e-03 | 20 | 154 | 2 | C0011052 | |
| Disease | monocyte percentage of leukocytes | 5.17e-03 | 731 | 154 | 10 | EFO_0007989 | |
| Disease | Prostatic Neoplasms | 5.19e-03 | 616 | 154 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.19e-03 | 616 | 154 | 9 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFGLSIATMVQCFGH | 76 | P55087 | |
| TAGCKTTTSAVMVHC | 271 | P23141 | |
| KESFSSIMCFGCHDV | 1276 | P53355 | |
| CHSNQTAFHGCMELL | 496 | P78357 | |
| MEGCHSFSASCLTQF | 391 | P45844 | |
| ICRCTHLSSFAVLMA | 511 | Q9UHX3 | |
| CQCTHLTSFSILMSP | 561 | Q5T601 | |
| CMATCHSLTKIEGVL | 541 | Q9H7F0 | |
| HSLFTVCCNSPRTLM | 371 | Q9Y574 | |
| TLIAIAGMTCASCVH | 361 | P35670 | |
| IELTITGMTCASCVH | 566 | P35670 | |
| TGMTCASCVHNIESK | 571 | P35670 | |
| TTCACSHLTNFAVLM | 831 | O94910 | |
| EVYNCRGSHVLSCMV | 1416 | Q9UIG0 | |
| QILTQDHGMELICCF | 236 | Q7Z5W3 | |
| MTTTCNHALYAICDV | 1451 | Q9Y6D6 | |
| SCGIHETTFNSIMKC | 271 | P60709 | |
| SCGIHETTFNSIMKC | 271 | P63261 | |
| FCLRATCIMNHEAVS | 336 | Q9Y3Q7 | |
| CTALMLAVCHGSSEI | 206 | Q9BXX3 | |
| TFMCLALHCIANVGS | 126 | O95782 | |
| SNMCCGTHVSNLSDL | 206 | Q9BTE6 | |
| SMHCCTLGFLSCSLF | 721 | Q8NFM4 | |
| VACQCSHTASFAVLM | 2441 | Q9NYQ6 | |
| QTACHLNMEASLICS | 776 | Q9NR16 | |
| LSHIAPAFCMSSCSF | 1061 | Q9UPW5 | |
| SFCSIFNMPTCVLHC | 286 | Q96I13 | |
| IHCCGVYTGNMTLAA | 916 | Q6IQ32 | |
| FIIDGMHCKSCVSNI | 281 | Q04656 | |
| TCFHNIGEMCTKSLT | 441 | Q6ZP01 | |
| LASFCQEMQHVICTG | 576 | Q8TE59 | |
| SEEGMKVSCTHFQCA | 136 | Q9H3S7 | |
| ACATQLGCFLTFMVS | 96 | P0C7N1 | |
| SCCFISEDLMVNHFL | 1121 | Q9P260 | |
| MTECISLASGCHQAL | 121 | Q9Y442 | |
| SVCGRCHTTHSMALI | 326 | P33991 | |
| SFGGCLAQMFCVHSI | 96 | Q9H346 | |
| LKAFNTCGSHVCVML | 236 | Q8NGH9 | |
| CECMNNSTCDHVTGT | 796 | A6BM72 | |
| AVNYCGLETILHMTC | 116 | P42898 | |
| LCTAHMCSTLEHNCA | 236 | O00339 | |
| LMVNVCGHTLCESCV | 21 | P51948 | |
| SECGFHMVACNSSVT | 241 | Q68DU8 | |
| VCHLLAMASTCVNPF | 306 | P50391 | |
| HCLCSLTGHQEAQFM | 831 | Q6ZRS4 | |
| ATCSLCHGSKFSMLA | 206 | A6NFK2 | |
| HVTCSMKDVGSTIGC | 821 | Q38SD2 | |
| SCSLAGIKCQMDHTA | 251 | Q96S65 | |
| AVVGFAISLSSMACC | 106 | O95528 | |
| MGEKLSCTSNHLAEC | 1056 | Q9BQS8 | |
| SCTSNHLAECQAAML | 1061 | Q9BQS8 | |
| AENFCVCHLATGDML | 36 | P54819 | |
| SCQAMFNIQGCHLTT | 81 | Q9Y231 | |
| ITVDCDQCTMVTQHG | 116 | O43679 | |
| CIQCSMPSCVTAFHV | 321 | Q9NQC1 | |
| MPSCVTAFHVTCAFD | 326 | Q9NQC1 | |
| SYHLMGGICTSDCLV | 1641 | Q92824 | |
| VLMNHRVCLFLSSGC | 166 | Q8NH00 | |
| TFCEHMGIAHLSCSD | 196 | Q8NGF0 | |
| CNTCASHLMVVTLLF | 241 | Q8NGJ0 | |
| KTVLMNHCSGSCGTF | 5091 | Q02817 | |
| VYMVHRSCGTSCFEL | 481 | Q9Y233 | |
| MTHCTGKENHCVSLS | 141 | A6NC86 | |
| CHFVTMCIFTCTGQH | 526 | P16050 | |
| MCIFTCTGQHASVHL | 531 | P16050 | |
| FTCTTCNKMLTTGDH | 141 | P50458 | |
| LKMECSETHVQGSCA | 826 | Q96QE4 | |
| HTGFLDTCLKDCMLT | 726 | Q9BSJ2 | |
| CSQMCHNVFIVESVC | 261 | Q9UIX4 | |
| CHFLTMCVFTCTAQH | 526 | P18054 | |
| SLIHTCLMAQLTFCA | 156 | O60431 | |
| ATAHTGCMLRLTFCS | 156 | Q8NGG8 | |
| TISFSACMVQHLCFG | 91 | Q8NH18 | |
| ACMVQHLCFGVFITT | 96 | Q8NH18 | |
| QCSCSLHIMGDGSKA | 26 | Q9P2V4 | |
| SDNILCHFCASMISG | 216 | Q02978 | |
| CHFCASMISGLVTTA | 221 | Q02978 | |
| SIAFPLLCTHFMSCT | 566 | Q9Y2A7 | |
| ISFITSMSEHFCGTC | 301 | Q9NZB8 | |
| LTFAMSCTAHVFSCL | 131 | Q6ZVX9 | |
| CIHFISVLFGLLCSM | 91 | Q5TIA1 | |
| HGIMCTGFLCNFSTE | 116 | Q86VF5 | |
| KAFSTCSSHLCMVGL | 236 | Q96R48 | |
| CSSHLCMVGLFFGSA | 241 | Q96R48 | |
| ALSTCASHFMVVCLF | 236 | Q9UGF7 | |
| NLVMSCGISVEFCSH | 1156 | O15118 | |
| FMCATCQTGESTSHV | 676 | Q9QC07 | |
| SDHTCCVQMVDSEFQ | 1636 | Q8NCM8 | |
| EVLHVTDTMFQGCGC | 701 | Q9BXL6 | |
| IDCHTDVILCMSFNT | 176 | Q9UQ03 | |
| VTTLLECMHKLGNSC | 616 | P55265 | |
| MKVFVCCASTSHSGE | 161 | P52797 | |
| CSEICGANHSFMPIV | 196 | P00403 | |
| SSTVCGQDLQSHLCM | 326 | P01133 | |
| TSRLAVICGTSSCHM | 286 | Q96C11 | |
| VICGTSSCHMGISKD | 291 | Q96C11 | |
| QSLVSHCTCPVQFSM | 211 | Q8NHY3 | |
| TIGCSSCSSLMEHFE | 141 | Q99871 | |
| ATQVTETLGMTHCCI | 286 | P41597 | |
| CMIGHCLSSQEEFLQ | 1646 | Q99698 | |
| MSHLGCLTINCDSIE | 356 | A6NNW6 | |
| HLTNESVCEIMQSCF | 151 | Q92538 | |
| LLLMFHCVGSQDSKC | 81 | Q5JSQ8 | |
| SHINQLMCDSDGSCA | 2686 | Q5TBA9 | |
| MLTSFCGALHVCFIT | 96 | P42261 | |
| NMAGLVNLSHCFLCT | 241 | P60507 | |
| THQFCAMALTLTLCA | 226 | Q6T423 | |
| CIHSCFQESMIKECG | 416 | P37088 | |
| GLLHAMCTLCFAVTG | 1141 | Q9BY12 | |
| FIRNLGVHICSSMCD | 461 | O15244 | |
| NMASFTKHICAICGD | 126 | P19793 | |
| ASCNDTVICMALVQH | 701 | Q8WUF5 | |
| CMTQTFLCLSFGHSE | 96 | Q8NGT9 | |
| CLFLCHLSFLDMTIS | 81 | Q8NH81 | |
| ATAHTGCMLRLTFCS | 156 | Q96RD0 | |
| MAAIGVHLGCTSACV | 1 | Q0VDF9 | |
| SFFNLECCVSGTHSM | 186 | Q6QHF9 | |
| FGACITQMYTIHICT | 96 | Q8NH55 | |
| ALSTCGSHVCVMLAF | 236 | Q8NH55 | |
| ACATQLGCFLTFMIS | 96 | Q8NH10 | |
| ACILIGCAMNFTTLH | 231 | Q5M8T2 | |
| RQQCLFHSMVCDGII | 1286 | Q92673 | |
| HCEQVVFTACMTLTA | 176 | Q9NWD8 | |
| HQSEQTLCVVCMCDF | 456 | Q9H0F5 | |
| CNVTQDMLCTHEETF | 426 | P51649 | |
| LFQNMTCELHLTCSV | 141 | Q96DU3 | |
| TDSNGICMHLGLCKS | 131 | P07988 | |
| DSECHLCMSVTTQAG | 296 | P07988 | |
| AHTTCQALGVCGTMS | 356 | P07988 | |
| SCIVCNMGHSNTEID | 391 | O43865 | |
| TSNDACLSIVHSLMC | 11 | Q13485 | |
| SLCAHKAGCQVASTM | 156 | Q99519 | |
| DFCPTNCHINLMEVS | 966 | Q8TCU6 | |
| QHLSSMAPECCVACS | 511 | Q6ZNE9 | |
| LMAACFTFCLSHQNL | 21 | Q9H173 | |
| TQEMEFCETSHTLCS | 71 | Q9UKZ4 | |
| GKQASHVSCTVEMCS | 266 | Q8IYB8 | |
| ACATQLGCFLTFMIT | 96 | Q8NH85 | |
| SICLACFCANGHIMT | 956 | Q5T5C0 | |
| CFCANGHIMTFSLPS | 961 | Q5T5C0 | |
| MCPSVCESSHFAVLL | 1516 | O60287 | |
| TFASCSTDMCIHVCK | 321 | Q9BZK7 | |
| FCSSDHLCLLASFGM | 651 | Q9UNK9 | |
| NDCGKTFSHMSTLTC | 386 | Q8N782 | |
| VCEMCTKGFTTQAHL | 306 | O43829 | |
| QTHTGTDMAVFCLLC | 481 | Q05516 | |
| CGKAFSQCSLLIIHM | 591 | Q3ZCX4 | |
| CDCSVCGEVFMHQVS | 156 | Q9ULM2 | |
| TFASCMHILSEETCF | 421 | Q6NUQ1 | |
| HMFSPSCVSLLRCTG | 71 | P49763 | |
| GTSCLEQLAELVHCM | 366 | Q9P2H5 | |
| SACSDVHMALCAVNL | 686 | Q12772 | |
| MSGHSNFVSCVCIIP | 61 | Q9Y263 | |
| VCHLLAMASTCVNPF | 306 | P0DQD5 | |
| VCSGHQSFMAPSCSV | 256 | O94813 | |
| TFASCSTDMCIHVCR | 331 | Q9BQ87 | |
| KCMECGSSHDTLQQL | 381 | Q9NRE2 | |
| VLSHIGIFLFSCDMC | 391 | O15060 | |
| HGCLFCAFTTSSMEL | 1001 | O15090 | |
| TCNSMVLFDHVGCLK | 996 | P11388 | |
| VSVACLNSDCHMATA | 51 | P0C7T8 | |
| ASFVQCCLFHESGMP | 156 | Q9BWM5 | |
| FCSLCHATFNDPVMA | 186 | Q9UL40 | |
| VNMEFTCDHCQGLII | 1826 | O43149 | |
| CDMTFPCFSELISHQ | 346 | Q96LX8 | |
| LCMACVFEVSNSEHG | 401 | P28347 | |
| VSHVQLACSMQDCAF | 31 | A2RRH5 | |
| MASSIICQEHCQISG | 1 | Q9NX45 | |
| SAIFPDVALMNHSCC | 196 | Q9NRG4 | |
| MSHTASSCQELVENC | 1 | Q9Y2D9 | |
| HFVCGGLAACMATLT | 121 | Q9HC21 | |
| IASQDGVHCLTCAIM | 671 | Q9NYI0 | |
| GVHCLTCAIMLLNTD | 676 | Q9NYI0 | |
| ECGKSFCMLSHLTQH | 186 | Q8NEM1 | |
| NNDTCSMPGLTCFTH | 716 | Q8IWU5 | |
| LKCMECGSSHDTLQQ | 416 | Q6ZSZ6 | |
| VCHICSIAFTSLDMF | 176 | Q5H9K5 | |
| FRQLTTHKCMGDSCI | 61 | Q70EL1 | |
| DVCVRHFLQATGCSM | 336 | Q9Y303 |